Evolving SARS-CoV-2 Detection Technologies and Surveillance
*Corresponding Author:Received Date: Nov 03, 2025 / Accepted Date: Dec 01, 2025 / Published Date: Dec 01, 2025
Citation: Scott N (2025) Evolving SARS-CoV-2 Detection Technologies and Surveillance. awbd 14: 325.DOI: 10.4172/2167-7719.1000325
Copyright: © 2025 Nathan Scott This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,distribution and reproduction in any medium, provided the original author and source are credited.
Abstract
SARS-CoV-2 detection and surveillance strategies have rapidly evolved. RT-qPCR remains the gold standard, complemented by antigen-based rapid tests for mass screening. Innovative technologies like CRISPR, point-of-care molecular diagnostics, and biosensors offer portable, sensitive solutions. Wastewater surveillance and saliva sampling enhance public health monitoring and patient comfort. Next-generation sequencing is crucial for genomic surveillance and variant tracking. Artificial Intelligence (AI) is transforming diagnostics through image analysis and disease prediction, enhancing accuracy and speed. These advancements collectively improve global pandemic response and clinical decision-making.
